We are live on ! Find out more
RE

RBC Europe Portfolio holdings

AUM $2.08B
1-Year Est. Return 12.2%
This Fund
S&P 500
This Quarter Est. Return
+10.57%
1 Year Est. Return
-12.2%
3 Year Est. Return
+59.81%
5 Year Est. Return
+127.03%
10 Year Est. Return
AUM
$2.21B
AUM Growth
+$346M
Cap. Flow
+$155M
Cap. Flow %
7.01%
Top 10 Hldgs %
52.87%
Holding
1,270
New
89
Increased
248
Reduced
136
Closed
37

Top Buys

Rank Stock Value
1
ICE icon
Intercontinental Exchange
ICE
+$57.1M
2
FAST icon
Fastenal
FAST
+$18.4M
3
AMZN icon
Amazon
AMZN
+$8.95M
4
DIS icon
Walt Disney
DIS
+$7.75M
5
PFE icon
Pfizer
PFE
+$7.01M

Sector Composition

Rank Sector Weight
1 Technology 26.19%
2 Financials 24.54%
3 Consumer Discretionary 15.79%
4 Communication Services 11.43%
5 Healthcare 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FKWL icon
1151
Franklin Wireless
FKWL
$29.6M
$1.56K ﹤0.01%
170
SYF icon
1152
Synchrony
SYF
$25.4B
$1.55K ﹤0.01%
32
ARLP icon
1153
Alliance Resource Partners
ARLP
$3.37B
$1.53K ﹤0.01%
212
XONE
1154
DELISTED
The ExOne Company
XONE
$1.51K ﹤0.01%
70
PJT icon
1155
PJT Partners
PJT
$4.67B
$1.5K ﹤0.01%
21
FHTX icon
1156
Foghorn Therapeutics
FHTX
$356M
$1.49K ﹤0.01%
140
QTTB icon
1157
Q32 Bio
QTTB
$447M
$1.47K ﹤0.01%
11
ADNT icon
1158
Adient
ADNT
$1.47B
$1.45K ﹤0.01%
32
STEM.WS
1159
DELISTED
Stem, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise pri
STEM.WS
$1.43K ﹤0.01%
+60
New +$894
UBX
1160
DELISTED
Unity Biotechnology
UBX
$1.39K ﹤0.01%
30
GOSS icon
1161
Gossamer Bio
GOSS
$83.2M
$1.37K ﹤0.01%
169
CMPS
1162
Compass Pathways
CMPS
$1.9B
$1.33K ﹤0.01%
35
LOGC
1163
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$1.22K ﹤0.01%
275
TRIP icon
1164
TripAdvisor
TRIP
$1.16B
$1.21K ﹤0.01%
+30
New +$1.35K
KF
1165
Korea Fund
KF
$267M
$1.2K ﹤0.01%
26
NBR icon
1166
Nabors Industries
NBR
$1.39B
$1.14K ﹤0.01%
10
TWOU
1167
DELISTED
2U Inc
TWOU
$1.13K ﹤0.01%
1
SIVB
1168
DELISTED
SVB Financial Group
SIVB
$1.11K ﹤0.01%
+2
New +$1.11K
RMR icon
1169
The RMR Group
RMR
$332M
$1.08K ﹤0.01%
28
LAB icon
1170
Standard BioTools
LAB
$252M
$1.06K ﹤0.01%
172
PBR icon
1171
Petrobras
PBR
$119B
$1.03K ﹤0.01%
84
KN icon
1172
Knowles
KN
$2.92B
$1.03K ﹤0.01%
52
IPOF
1173
DELISTED
Social Capital Hedosophia Holdings Corp. VI
IPOF
$1.02K ﹤0.01%
100
QCLS
1174
Q/C Technologies Inc
QCLS
$19.2M
0
MLR icon
1175
Miller Industries
MLR
$644M
$986 ﹤0.01%
25

Similar funds

RBC Europe's Q2 2021 Portfolio in Review

As of Q2 2021, RBC Europe held 1,270 positions worth $2.21B, up 19% from $1.86B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

RBC Europe deployed $155M of net new capital in Q2 2021, opening 89 new positions and adding to 248 existing holdings. Its largest new stake was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 20,190 shares worth $1.95M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Toronto Dominion Bank, an estimated $5.8M trimmed.

  • RBC Europe's largest Q2 2021 buy was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 20,190 shares worth $1.95M.
  • RBC Europe added most to Intercontinental Exchange in Q2 2021, an estimated $57.1M increase.
  • RBC Europe's biggest Q2 2021 reduction was Toronto Dominion Bank, cutting an estimated $5.8M.
  • RBC Europe fully exited GW Pharmaceuticals Plc American Depositary Shares in Q2 2021, selling an estimated $1.45M.
  • RBC Europe's ten largest holdings make up 53% of its $2.21B portfolio in Q2 2021.
  • RBC Europe opened 89 new positions and closed 37 in Q2 2021.
  • RBC Europe's portfolio value rose 19% quarter-over-quarter to $2.21B.

Based on RBC Europe's 13F filing for Q2 2021, filed 9 Nov 2023.